The historical rank and industry rank for Plant Based Investment's Pretax Margin % or its related term are showing as below:
CWWBF's Pretax Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.295 * Ranked among companies with meaningful Pretax Margin % only.
Plant Based Investment (OTCPK:CWWBF) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Plant Based Investment Pretax Margin % Related Terms
Plant Based Investment Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Plant Based Investment's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CWWBF vs ZTS, CTLT, VTRS: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Plant Based Investment's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Plant Based Investment Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Plant Based Investment's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Plant Based Investment's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Plant Based Investment (CWWBF) has a Pretax Margin % of 114.25% as of Jul. 2022. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Plant Based Investment and its competitors.
Is Plant Based Investment's Pretax Margin % too high?
Plant Based Investment's current Pretax Margin % is 114.25%. The Drug Manufacturers industry median Pretax Margin % is 7.30. Plant Based Investment's value of 114.25% is 1466.1% above this industry median.
How does Plant Based Investment's Pretax Margin % compare to ZTS and CTLT?
Plant Based Investment's Pretax Margin % of 114.25% can be compared against companies in the Drug Manufacturers industry. The industry median Pretax Margin % is 7.30. Plant Based Investment's value of 114.25% is 1466.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Plant Based Investment's current Pretax Margin % of 114.25% is 1466.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Plant Based Investment and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Plant Based Investment's current Pretax Margin % is 114.25%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Plant Based Investment stock overvalued right now?
Plant Based Investment (CWWBF) has a current Pretax Margin % of 114.25%. The current Pretax Margin % is 114.25% and 1466.1% above the Drug Manufacturers industry median of 7.30. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Plant Based Investment (CWWBF), the current Pretax Margin % is 114.25% as of Jul. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Plant Based Investment Corp is an investment corporation that seeks to provide shareholders long-term total returns through capital appreciation and periodic distributions by investing in an actively managed portfolio of securities in public and private companies that derive a portion of their revenues, earnings or intellectual property-based value from products, equipment, services and/or technologies related to plant-based industries, including the cannabis plant family and its various compounds, the fungi industry (including medicinal, functional and psychedelics), super-foods and/or organic ingredients industries in addition to investing in specialty retail locations, functional medicine and wellness-based clinics and treatment centers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CWWBF has been successfully added to your 